Overview
Status
Suspended
Registry date
2018-03-28
Share capital
10,000.00 PLN
Registered address
pl. Solny 15, 50-062 Wrocław, Poland
Email
Financials
Revenue history
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 90 days late).
- 202514/07/2026
- 202418/06/2025
- 202310/07/2024
- 202214/07/2023
- 202113/10/2022
- 202008/10/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Michał Moś – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Michał Mośage 47 | 90 | $2,431.12 | 90% |
Ewa Cecylia Rogożage 49 | 10 | $270.12 | 10% |
Beneficial owners
No beneficial owners recorded for the company Energene.
Bank accounts
Was a VAT taxpayer from 2018-04-24 to 2026-01-08.
Reason for removal: Art. 96 ust. 9a pkt 1 (business activity suspended for at least 6 consecutive months)
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| EIT Rawmaterials Clc Eastsp. z o.o. | $1,795,803.10 | eitrawmaterials.eu | ||
| Centrum Innowacji i Wdrożeń Bio-Inwestsp. z o.o. | $1,262,872.91 | bio-inwest.pl | ||
| Vitrotest Europesp. z o.o. | $233,350.77 | vitrotest.pl | ||
| VASA Therapeuticssp. z o.o. | $216,535.01 | vasatherapeutics.com | ||
| Bactremsp. z o.o. | $181,958.36 | bactrem.pl | ||
| MultiqureS.A. | $149,394.35 | purebiologics.com | ||
| GenomtecS.A. | $54,746.36 | genomtec.com | ||
| Centrum Transferu Technologii Meditransfer Iitdsp. z o.o. | $228.56 | iitd.pan.wroc.pl | ||
| Olenasp. z o.o. | – | imsolutions.pl | ||
| Dystrogen TherapeuticsS.A. | – | dystrogen.com |
Change history
| Date | Event | |
|---|---|---|
| 2025-05-14 | Business suspended | |
| 2025-01-01 | Business resumed | |
| 2022-12-31 | Business suspended | |
| 2021-09-03 | Business resumed | |
| 2021-06-21 | Business suspended |
FAQ
The main business activity of Energene focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on March 28, 2018.
The headquarters is located at: Pl. Solny 15, 50-062 Wrocław.
The management board consists of: Michał Moś (President of the Management Board).
The share capital of the company is PLN 10,000 (approx. $2,701).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
Last updated: 2026-07-17